Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications
Author:
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2012.03801.x/fullpdf
Reference33 articles.
1. Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery;Karkouti;Circulation,2008
2. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion;Spinella;J Trauma,2008
3. Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients;Felfernig;Clin Neurol Neurosurg,2008
4. The use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery;Walsham;Anaesth Intensive Care,2006
5. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis;Gelsomino;Eur J Cardiothorac Surg,2008
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The impact of bleeding on outcomes following lung transplantation: a retrospective analysis using the universal definition of perioperative bleeding;Journal of Cardiothoracic Surgery;2024-07-25
2. Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding;Anesthesiology;2023-05-08
3. Intraoperative Red Blood Cell Transfusion and Primary Graft Dysfunction After Lung Transplantation;Transplantation;2023-03-24
4. Lung Retransplantation;Thoracic Surgery Clinics;2022-05
5. Comparative effectiveness of "liberal" and "restrictive" modes of intraoperative infusion-transfusion therapy in lung transplantation;Transplantologiya. The Russian Journal of Transplantation;2021-09-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3